AMGN (STOCKS)
Amgen Inc
$349.620000
-1.400000 (-0.40%)
Prev close: $351.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert A. Bradway
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $188,571.38M
- Employees
- 28,000
- P/E (TTM)
- 24.67
- P/B (TTM)
- 21.84
- Dividend Yield
- 275.20%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
15
Buy
19
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$5.29 | $4.83 | +0.4617 | +9.56% |
|
Sep 2025 (Q3)
|
$5.64 | $5.11 | +0.5256 | +10.28% |
|
Jun 2025 (Q2)
|
$6.02 | $5.39 | +0.6276 | +11.64% |
|
Mar 2025 (Q1)
|
$4.90 | $4.39 | +0.5145 | +11.73% |
Financial Statements
| Revenues | $36.75B |
| Benefits Costs and Expenses | $27.78B |
| Cost Of Revenue | $12.04B |
| Costs And Expenses | $27.67B |
| Gross Profit | $24.71B |
| Nonoperating Income/Loss | $2.65B |
| Operating Expenses | $15.63B |
| Selling, General, and Administrative Expenses | $7.05B |
| Depreciation and Amortization | $887.00M |
| Other Operating Expenses | $7.70B |
| Operating Income/Loss | $9.08B |
| Income/Loss From Continuing Operations After Tax | $7.71B |
| Income/Loss From Continuing Operations Before Tax | $8.98B |
| Income Tax Expense/Benefit | $1.27B |
| Income Tax Expense/Benefit, Current | $1.97B |
| Income Tax Expense/Benefit, Deferred | -$700.00M |
| Net Income/Loss | $7.71B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $7.71B |
| Net Income/Loss Available To Common Stockholders, Basic | $7.71B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $14.33 |
| Diluted Earnings Per Share | $14.23 |
| Basic Average Shares | 538,000,000 |
| Diluted Average Shares | 542,000,000 |
| Assets | $90.59B |
| Current Assets | $29.06B |
| Inventory | $6.23B |
| Other Current Assets | $22.83B |
| Noncurrent Assets | $61.53B |
| Fixed Assets | $7.91B |
| Intangible Assets | $22.28B |
| Other Non-current Assets | $31.34B |
| Liabilities | $81.93B |
| Current Liabilities | $25.49B |
| Accounts Payable | $2.37B |
| Wages | $1.44B |
| Other Current Liabilities | $21.69B |
| Noncurrent Liabilities | $56.44B |
| Long-term Debt | $54.60B |
| Other Non-current Liabilities | $1.84B |
| Equity | $8.66B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.66B |
| Liabilities And Equity | $90.59B |
| Net Cash Flow From Operating Activities | $9.96B |
| Net Cash Flow From Operating Activities, Continuing | $9.96B |
| Net Cash Flow From Investing Activities | -$1.94B |
| Net Cash Flow From Investing Activities, Continuing | -$1.94B |
| Net Cash Flow From Financing Activities | -$10.86B |
| Net Cash Flow From Financing Activities, Continuing | -$10.86B |
| Net Cash Flow | -$2.84B |
| Net Cash Flow, Continuing | -$2.84B |
| Comprehensive Income/Loss | $7.52B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $7.52B |
| Other Comprehensive Income/Loss | $7.52B |
| Other Comprehensive Income/Loss Attributable To Parent | -$192.00M |